Current:Home > ScamsNovo Nordisk will cut some U.S. insulin prices by up to 75% starting next year-LoTradeCoin
Novo Nordisk will cut some U.S. insulin prices by up to 75% starting next year
View Date:2024-12-24 00:14:12
Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly.
The Danish drugmaker said Tuesday that pre-filled pens and vials of long- and short-acting insulins will see list price reductions. They include Levemir, Novolin, NovoLog and NovoLog Mix70/30.
Novo also will drop the list price of unbranded products like Insulin Aspart to match the lower price of the branded insulins.
The price cuts go into effect Jan. 1. A vial of NovoLog and NovoLog Mix 70/30 will drop 75% to $72.34 from $289.36. FlexPen options will fall to $139.71 from more than $500.
Levemir and Novolin vials and FlexPens will drop 65% from their current list prices.
List prices are what a drugmaker initially sets for a product and what people who have no insurance or plans with high deductibles are sometimes stuck paying.
Patient advocates have long called for insulin price cuts to help uninsured people who would not be affected by price caps tied to insurance coverage. They have noted that high insulin prices force many people to ration doses, which can be dangerous for their health.
Research has shown that prices for insulin have more than tripled in the last two decades. Pressure is growing on drugmakers to help patients.
Insulin affordability in the United States depends largely on whether patients have health insurance and the details of that coverage. People with employer-sponsored coverage, for instance, may pay little out of pocket for their insulin or they might pay hundreds of dollars if they must first meet a high deductible before the coverage kicks in.
High deductibles also are common with coverage purchased through the individual insurance market.
Major insulin makers like Lilly, Novo and the French pharmaceutical company Sanofi have said they offer several assistance programs to help patients with costs. Those can include free refills for people with low incomes and cheaper versions of older insulins.
But high list prices remain a problem.
Eli Lilly and Co. CEO David Ricks noted earlier this month that discounts the drugmaker offers from its list prices often don't reach patients through insurers or pharmacy benefit managers.
The Indianapolis-based drugmaker said March 1 that it will cut the list prices for its most commonly prescribed insulin, Humalog, and for another insulin, Humulin, by 70% or more in the fourth quarter, which starts in October.
The federal government in January started applying a $35 cap on monthly out-of-pocket costs to patients with coverage through its Medicare program for people age 65 and older or those who have certain disabilities or illnesses.
Insulin is made by the pancreas and used by the body to convert food into energy. People who have diabetes don't produce enough insulin. Those with Type 1 diabetes must take insulin every day to survive.
More than 8 million Americans use insulin, according to the American Diabetes Association.
The Wall Street Journal first reported the price cuts Tuesday morning.
veryGood! (571)
Related
- Georgia House Democrats shift toward new leaders after limited election gains
- BP oil refinery in Indiana resumes normal operations weeks after power outage, temporary shutdown
- Sergeant faulted for actions before Maine mass shooting is running for sheriff
- Armed thieves steal cash from guards collecting video machine cash boxes in broad daylight heist
- What Happened to Kevin Costner’s Yellowstone Character? John Dutton’s Fate Revealed
- Over-the-counter birth control pill now available to Wisconsin Medicaid patients
- Whoopi Goldberg Reveals the Weight Loss Drug She Used to Slim Down
- How Bruce Willis' Family Is Celebrating His 69th Birthday Amid Dementia Battle
- What happens to Donald Trump’s criminal conviction? Here are a few ways it could go
- Sophie Turner and Joe Jonas Fail to Reach Divorce Settlement
Ranking
- Will the NBA Cup become a treasured tradition? League hopes so, but it’s too soon to tell
- Russia's Vladimir Putin hails election victory, but critics make presence known despite harsh suppression
- Don't Miss Out on These Early Fashion Deals From Amazon's Big Spring Sale That Include Up to 66% Off
- March Madness gets underway with First Four. Everything to know about men's teams.
- Jennifer Hudson, Kylie Minogue and Billy Porter to perform at Macy’s Thanksgiving Parade
- Russian woman kidnapped near U.S. border in Mexico is freed, officials say
- What the 'mission from God' really was for 'The Blues Brothers' movie
- Key questions as Trump hurtles toward deadline to pay $454 million fraud penalty
Recommendation
-
Oregon's Dan Lanning, Indiana's Curt Cignetti pocket big bonuses after Week 11 wins
-
University of Maryland lifts Greek life ban, hazing investigation into five chapters continues
-
March Madness expert picks: Our bracket predictions for 2024 NCAA men's tournament
-
Missing Wisconsin toddler's blanket found weeks after he disappeared
-
US overdose deaths are down, giving experts hope for an enduring decline
-
Supreme Court opens new frontier for insurrection claims that could target state and local officials
-
Congressional leaders, White House reach agreement on funding package as deadline to avert government shutdown nears
-
What to know about Paige Bueckers, UConn's star who's healthy and back to dominating ways